A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calusterone
Butylscopolamine
The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Nabiximols.
Calusterone
Imidafenacin
The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with Nabiximols.
Calusterone
Trimebutine
The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with Nabiximols.
Calusterone
Dexetimide
The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with Nabiximols.
Calusterone
Aclidinium
The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with Nabiximols.
Calusterone
Dimetindene
The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with Nabiximols.
Calusterone
Hexocyclium
The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Nabiximols.
Calusterone
Mepenzolate
The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with Nabiximols.
Calusterone
Isopropamide
The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with Nabiximols.
Calusterone
Solifenacin
The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with Nabiximols.
Chloral hydrate
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Medical Cannabis.
Chloral hydrate
Satralizumab
The serum concentration of Medical Cannabis can be decreased when it is combined with Satralizumab.
Chloral hydrate
Abametapir
The serum concentration of Medical Cannabis can be increased when it is combined with Abametapir.
Chloral hydrate
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Medical Cannabis.
Chloral hydrate
Cenobamate
The serum concentration of Medical Cannabis can be decreased when it is combined with Cenobamate.
Chloral hydrate
Siponimod
The risk or severity of adverse effects can be increased when Medical Cannabis is combined with Siponimod.
Chloral hydrate
Solriamfetol
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Medical Cannabis.
Chloral hydrate
Chlorphenoxamine
The risk or severity of Tachycardia can be increased when Chlorphenoxamine is combined with Medical Cannabis.
Chloral hydrate
Otilonium
The risk or severity of Tachycardia can be increased when Otilonium is combined with Medical Cannabis.
Chloral hydrate
Propiverine
The risk or severity of Tachycardia can be increased when Propiverine is combined with Medical Cannabis.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3